1 – 10 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria
2024) In Movement Disorders(
- Contribution to journal › Article
-
Mark
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
(
- Contribution to journal › Article
- 2023
-
Mark
Co-occurrence of CLCN2-related leukoencephalopathy and SPG56
(
- Contribution to journal › Article
- 2021
-
Mark
Genotype–Phenotype Relations for the Atypical Parkinsonism Genes : MDSGene Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Pharmacological Medical Treatment of Epilepsy in Patients with Dementia : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Seizures and Epilepsy in Dementia : Diagnosis and Management
2021) p.251-290(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2020
-
Mark
Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies
(
- Contribution to journal › Article
-
Mark
Cognitive and psychiatric symptoms are associated with walking difficulties in mild Parkinson’s disease
(
- Contribution to conference › Abstract
-
Mark
C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts
(
- Contribution to journal › Article
- 2019
-
Mark
Swedish Version of the Hayling Test : Clinical Utility in Frontotemporal Dementia Syndromes
(
- Contribution to journal › Article